Zobrazeno 1 - 10
of 149
pro vyhledávání: '"Irit Ben‐Aharon"'
Autor:
Irit Ben-Aharon, Ran Rotem, Cheli Melzer-Cohen, Gilad Twig, Andrea Cercek, Elizabeth Half, Tal Goshen-Lago, Gabriel Chodik, David Kelsen
Publikováno v:
JMIR Public Health and Surveillance, Vol 9, p e50110 (2023)
BackgroundThe incidence of early-onset colorectal cancer (EOCRC) rose abruptly in the mid 1990s, is continuing to increase, and has now been noted in many countries. By 2030, 25% of American patients diagnosed with rectal cancer will be 49 years or y
Externí odkaz:
https://doaj.org/article/0dbc5b5dae594fe5ae39b751ae0d0346
Autor:
Galit Almog, Raphael M. Pfeffer, Svetlana Zalmanov, Vladislav Grinberg, Yoav Lipsky, Elena Chernomordikov, Daphne Levin, Sara Apter, Orit Arsenault, Dan Epstein, Qusai Tamimi, Keren Hod, Dror Limon, Talia Golan, Irit Ben-Aharon, Yaacov Richard Lawrence, Merav Akiva Ben-David
Publikováno v:
Frontiers in Oncology, Vol 13 (2023)
IntroductionStereotactic MR-guided on-table adaptive radiotherapy (SMART) allows the precise delivery of high-dose radiation to tumors in great proximity to radiation-sensitive organs. The aim of this study is to evaluate the toxicity and clinical ou
Externí odkaz:
https://doaj.org/article/4d8d9a43846e4540aa72a7e22f048a0d
Publikováno v:
Therapeutic Advances in Medical Oncology, Vol 14 (2022)
Background: Testicular toxicity following chemotherapy is of increasing importance with the continuous improvement of survival rates. Gonadotropin-releasing hormone (GnRH) was suggested to protect testis against such toxicity; however, its suppressiv
Externí odkaz:
https://doaj.org/article/e2d970aa68204069acd765fa56d66468
Publikováno v:
Frontiers in Oncology, Vol 12 (2022)
Tumor lysis syndrome (TLS) is a life-threatening oncological emergency rarely seen in solid tumors and is a complication of cancer therapy for rapidly proliferating tumors with devastating outcomes. BRAF and KRAS are two key oncogenes in the MAPK sig
Externí odkaz:
https://doaj.org/article/d6b2d3c385fc4befa0d6ecfe4a8f51a2
Autor:
Ilit Turgeman, Tal Goshen‐Lago, Ithai Waldhorn, Keren Karov, Leora Groisman, Anat Reiner Benaim, Ronit Almog, Michael Halberthal, Irit Ben‐Aharon
Publikováno v:
Cancer Reports, Vol 5, Iss 5, Pp n/a-n/a (2022)
Abstract Background The coronavirus disease 2019 (COVID‐19) crisis and consequent changes in medical practice have engendered feelings of distress in diverse populations, potentially adversely affecting the psychological well‐being of cancer pati
Externí odkaz:
https://doaj.org/article/ccae2e3431ce432384e26f7dd2ef841a
Publikováno v:
Frontiers in Reproductive Health, Vol 4 (2022)
Background:Gonadal toxicity following chemotherapy is an important issue among the population of young cancer survivors. The inhibitor of DNA topoisomerase I, irinotecan (CPT-11), is widely used for several cancer types. However, little is known abou
Externí odkaz:
https://doaj.org/article/7aa22dbc876140dbb8049eed66703776
Autor:
Oran Zlotnik, Tal Goshen‐Lago, Riad Haddad, Baruch Brenner, Yulia Kundel, Irit Ben‐Aharon, Hanoch Kashtan
Publikováno v:
Cancer Reports, Vol 5, Iss 3, Pp n/a-n/a (2022)
Abstract Background Esophageal cancer represents a global challenge. Despite significant evolution of treatment protocols in the past decade, recurrence rates are still high and survival rates are poor. Current treatment paradigm for localized gastro
Externí odkaz:
https://doaj.org/article/23eaad6a921b40b18f9fe67780a12fed
Autor:
Elisa Fontana, Florian Lordick, Irit Ben-Aharon, Tal Goshen-Lago, Ilit Turgeman, Elizabeth Smyth
Publikováno v:
ESMO Open, Vol 5, Iss 3 (2020)
Introduction Digital social networks have become a key player in the ecosystem of young patients with cancer, with regard to their unique perspectives and unmet needs. This study aims to investigate the web-based social community tools and to charact
Externí odkaz:
https://doaj.org/article/d7d45caee84d43a5a2d31a6e5ef2a26d
Autor:
Lihi Ninio-Many, Elad Hikri, Tamar Burg-Golani, Salomon M. Stemmer, Ruth Shalgi, Irit Ben-Aharon
Publikováno v:
Frontiers in Oncology, Vol 10 (2020)
The EGFR/HER2 signaling network is an effective therapeutic target for HER2-positive cancers, which are known for their aggressive biological course. Evidence indicates that the EGFR/HER2 network plays a role in the aggressive basal-like subtype as w
Externí odkaz:
https://doaj.org/article/fbbdc8a590294139b0e4b0d67c1ebab0
Autor:
Assaf Moore, Olga Ulitsky, Irit Ben‐Aharon, Gali Perl, Yulia Kundel, Michal Sarfaty, Ron Lewin, Liran Domachevsky, Hanna Bernstine, David Groshar, Nir Wasserberg, Hanoch Kashtan, Noa Gordon, Aaron Sulkes, Baruch Brenner
Publikováno v:
Cancer Medicine, Vol 7, Iss 11, Pp 5470-5477 (2018)
Abstract Background Current staging of pathological stage III colon cancer (CC) is suboptimal; many patients recur despite unremarkable preoperative staging. We previously reported that early postoperative PET‐CT can alter the stage and management
Externí odkaz:
https://doaj.org/article/9ec0ad6541be49af9746a62ec9479e48